JESSICA MILFORD: Open Payments
NPI 1215507264 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 58 payments from 14 companies in 2025. Trend: 2023 $1,980 · 2024 $2,245 · 2025 $1,261
Food & beverage: $1,261
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 5 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $197 |
| AstraZeneca Pharmaceuticals LP | 11 | $194 |
| Amgen Inc. | 7 | $117 |
| United Therapeutics Corporation | 4 | $101 |
| CVRx, Inc. | 4 | $100 |
| BridgeBio Pharma, Inc. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| SCPHARMACEUTICALS INC. | 2 | $44 |
| PFIZER INC. | 2 | $36 |
Products named: Kerendia, AMVUTTRA, WAINUA, REPATHA, Tyvaso, Barostim Neo System, Attruby, JARDIANCE.
Industry payments across NC — which companies pay providers there.
